Cancer cells have nutrient requirements distinct from normal cells and Zuma BioSciences exploits these differences to develop novel strategies for therapeutic intervention in cancer. Zuma BioSciences is transforming novel research in cellular metabolism from the Cerione laboratory at Cornell University into powerful new approaches in disrupting cancer cell growth by attacking the metabolic machinery which fuels oncogenesis.

News and Events

09.19.10

Molecule 968 Binds Glutaminase and Starves Cancer Cells ...more

09.13.10

Cancer Cell September Issue Cover Page on the role of "968" Inhibiting Cancer Cell Growth ...more